Course of coronary heart disease in patients with cardiovascular renal metabolic syndrome and separately metabolic

Introduction. Renal dysfunction is increasingly recognized as a key mediator of the association between metabolic risk factors and cardiovascular disease (CVD). Therefore, rather than simply viewing cardiorenal (CR) syndrome and cardiometabolic (CM) diseases as separate conditions, it is clear that we need to consider them as the broader concept of cardiovascular-renal-metabolic syndrome (CVMS). Purpose of the study: Studying the differences in the influence of SSMPS and separately metabolic (MS) on the course of coronary heart disease (CHD).